<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
COMMUNITY MEDICAL TRANSPORT, INC.
(Name of Issuer)
Common Stock, $ 0.001 par value
(Title of Class of Securities)
203744107
(CUSIP Number)
Thomas A. Huser, Esq.
Quadrant Management, Inc.
720 5th Avenue, 9th Floor
New York, New York 10019
212-231-3900
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 30, 1998
(Date of Event which Requires Filing
of this Statement
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of
Rule 13d-1 (b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [ ].
(Continued on following page (s)
Page 1 of 7 Pages
Exhibit Index Appears on Page 5)
<PAGE> 2
CUSIP NO. 203744107 13D Page 2 of 7 Pages
1 NAME OF REPORTING PERSON
SSN OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Herbard Limited (no Fed. I.D. No.)
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER (a) [ ]
OF A GROUP. (b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ]
IS REQUIRED PURSUANT TO ITEMS 2 (d) or 2 (e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands
- --------------------------------------------------------------------------------
NUMBER 7 SOLE VOTING POWER 92,366 Shares
OF --------------------------------------------------------------
WARRANTS
BENEFICIALLY 8 SHARED VOTING POWER NONE
OWNED --------------------------------------------------------------
BY
EACH 9 SOLE DISPOSITIVE POWER 92,366 Shares
REPORTING --------------------------------------------------------------
PERSON
WITH 10 SHARED DISPOSITIVE POWER NONE
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 92,366 Shares
- --------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES [ ]
CERTAIN SHARES
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.24%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON CO
- --------------------------------------------------------------------------------
<PAGE> 3
CUSIP NO. 203744107 13D Page 3 of 7 pages
Item 1 SECURITY AND ISSUER
This statement on Schedule 13D (the "Amendment"), filed with
respect to events that occurred on November 30, 1998, relates to shares of
Common Stock, par value $0.001 per share, of Community Medical Transport, Inc.,
a Delaware corporation (the"Common Stock" and the "Issuer", respectively), whose
principal executive offices are located at 4 Gannett Drive, White Plains, New
York, 10604. On December 2, 1998, the Shareholders of the Issuer approved and
the Issuer implemented a 1 for 6 reverse stock split.
Item 2 IDENTITY AND BACKGROUND
This Statement is filed by Herbard Limited, a British Virgin
Islands corporation ("Herbard").
Herbard may be deemed to be controlled by the Phyllis Quasha
Revocable Trust. Phyllis G. Quasha, as the settlor of the Trust, may be deemed
to control the Trust. Based upon the foregoing considerations, for purposes of
General Instruction C to Schedule 13D, the Phyllis Quasha Revocable Trust and
Phyllis G. Quasha (collectively, the "Instruction C Persons") may be deemed to
control Herbard.
Exhibit A sets forth the name, place of organization,
principal business, address of principal business and address of principal
office of Herbard and each Instruction C Person.
The name, citizenship, business address and present principal
occupation or employment of each executive officer and director of Herbard and
each of the Instruction C Persons, as well as the name, principal business and
address of the corporation or other organization in which such occupation or
employment is conducted, are set forth in Exhibit B.
During the five years prior to the date hereof, neither
Herbard nor, to the best of their knowledge, any of the Instruction C Persons or
any executive officer or director of Herbard or any of the Instruction C
Persons, (i) have been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors) or (ii) has been a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction, as a
result of which such person was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any violation with
respect to such laws.
Item 3 SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The funds for purchase by Herbard of the 65,000 shares of
pre-split Common Stock and 4300 shares of post-split Common Stock purchased from
November 20 through December 7, 1998, an aggregate of $42,272.10, came from the
general corporate funds of Herbard.
<PAGE> 4
CUSIP NO. 203744107 13D Page 4 of 7 Pages
Item 4 PURPOSE OF THE TRANSACTION
From November 20 though December 7, 1998, Herbard purchased an
aggregate of 65,000 shares of pre-split Common Stock and 4300 shares of
post-split Common Stock in transactions in the over-the-counter market, as part
of its short-term trading and long-term investment activities. Those
transactions are set forth in more detail in Exhibit F hereto.
Item 5 INTEREST IN SECURITIES OF THE ISSUER
(a) & (b) As of August 6, 1998, the Issuer had a total of
5,993,652 shares of Common Stock issued and outstanding according to information
made publicly available by the Issuer.
Pursuant to Rule 13d-3, the Reporting Person may be deemed to
beneficially own an aggregate of 92,366 Shares. Pursuant to Rule 13d-3 (d) (1)
(i), such 92,366 Shares constitute an aggregate of approximately 9.24% of the
outstanding Common Stock.
(c) Other than the transactions described in this Statement as
amended, no transactions in the shares of Common Stock have been effected during
the past 60 days by Herbard, or, any of the persons named in Exhibit B.
(d) Inapplicable
(e) Inapplicable
Item 6 Contracts, Arrangements, Understandings or Relationships with
respect to Securities of the Issuer.
Neither Herbard nor, to the best of its knowledge, any executive
officer or director thereof, has any contract, arrangement, understanding or
relationship with one or more security holders of the Issuer or others, with
respect to the purchase, holding, voting or disposition of shares of Common
Stock or other securities of the Issuer which are convertible or exercisable
into such shares. Each of such persons reserves the right to enter into any such
contract, arrangement, understanding or relationship in the future.
<PAGE> 5
CUSIP NO. 203744107 13D Page 5 of 7 Pages
Item 7 Material to be Filed as Exhibits Page
Exhibit A: Information concerning Previously filed
Reporting Persons and Instruction C Persons.
Exhibit B: Information concerning Previously filed
Reporting Persons' and Instruction C Persons' Officers,
Directors and Others.
Exhibit C: Power of Attorney of Previously filed
Herbard Limited granted to Thomas A. Huser.
Exhibit D: Information concerning Previously filed
other shares purchased within the last 60 days.
Exhibit E: Information concerning Previously filed
shares purchased October 6 though November 4,1998.
Exhibit F: Information concerning 7
shares purchased November 20 through December 7, 1998.
<PAGE> 6
CUSIP NO. 203744107 13D Page 6 of 7 Pages
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Dated: December 8, 1998
HERBARD LIMITED
By: /s/ Thomas A. Huser
-------------------------------
Thomas A. Huser
Attorney-in-Fact
<PAGE> 1
CUSIP NO. 203744107 13D Page 7 of 7 Pages
EXHIBIT F
PURCHASES OF SHARES NOVEMBER 20 THROUGH DECEMBER 7, 1998
<TABLE>
<CAPTION>
Date Number of Shares* Price Per Share*
- ---- ----------------- ----------------
<S> <C> <C>
11/20/98 28,000 $ .4844
11/24/98 27,000 $ .4832
11/30/98 10,000 $ .4375
12/7/98 4,300 $ 2.625
</TABLE>
* On December 2, the Shareholders of the Issuer approved and the Issuer
implemented a 6 for 1 reverse stock split.
